Briefings 13th Congress

Press Briefings on key-topics of the EHA Congress on Friday
June 13 and Saturday June 14, 2008 from 8:00 – 9:00 a.m., Meeting Room 16

Press briefings for the EHA Congress will be held at 8:00 – 9:00 a.m. on Friday June 13 and Saturday June 14 at the Bella Center Copenhagen. Top international experts will be on hand to provide you with an overview of the current and future developments within their field of expertise.

The preliminary program of the congress can be found on the internet at http://congress.ehaweb.org/13th/

PRESS BRIEFING on Friday June 13, 2008 from 8:00 – 9:00 a.m. Meeting Room 16

Highlights of EHA activities
Prof WIillem Fibbe - Leiden University Medical Centre, The Netherlands, President of the EHA
Thrombocytopenia
Prof James Bussel - NewYork-Presbyterian Hospital/Weill Cornell Medical Center, USA
Hodgkin’s Lymphoma
Prof Andrea Gallamini - Departments of Hematology and Nuclear Medicine, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy

Chronic Myeloid Leukemia
Prof Jorge Cortes - M.D.Anderson Cancer Center, Houston, TX, USA

PRESS BRIEFING on Saturday June 14, 2008 from 8:00 – 9:00 a.m. Meeting Room 16

Relation between Pharma and Academia
Prof Mike Greaves - Department of Medicine, University of Aberdeen, UK
Acute Myeloid Leukemia
Prof Hartmut Dohner - University Clinic Ulm, Germany

Multiple Myeloma
Prof Jesus San Miguel - University Hospital of Salamanca, Spain

CONTACT

B&K Medien- und Kommunikationsberatung GmbH
Dr. Birgit Kofler; Daniela Pedross, MA.
Porzellangasse 35/Top 3, A-1090 Vienna
Phone: 0043-01-319-43-78-11; Fax: 0043-01-319-43-78-20
Press Office: Phone during the Congress (June,12-15): 0045-32472103
E-mail: pedross@bkkommunikation.com

Targeted Drugs and Molecular Markers Improve Blood Cancer Therapies

New research results on improved treatments for various forms of blood cancer, such as multiple myeloma or acute myeloid leukemia, are presented by experts at the Congress of the European Hematology Association in Copenhagen. Participants are also engaged in critical debate of issues such as the relation between the pharmaceutics industry and scientists.

Experts Discuss Progress in Leukemia, Lymphoma and Low Blood Platelet Therapies

Hematological diseases are more widespread than is commonly assumed. Malignant blood disorders such as leukemia or lymphoma are newly diagnosed each year in more than 175,000 people in the European Union and more than 270,000 people in Europe as a whole. Several millions suffer from non-malignant blood diseases such as anemia and thrombosis. At the European Hematology Association Congress in Copenhagen , Denmark , experts share the results of new research on improved therapies for disorders such as low blood platelet count, Hodgkin’s lymphoma and leukemia.